189 related articles for article (PubMed ID: 36039201)
41. Unfolding the Mild to Moderate Short-Term Side Effects of Four COVID-19 Vaccines Used in Bahrain: A Cross-Sectional Study.
Zahid MN
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835300
[TBL] [Abstract][Full Text] [Related]
42. Are some COVID-19 vaccines better than others regarding the short-term side effects?
Al-Zidan R; Darweesh O; Salah M; Bebane P; Ahmed H; Abdulrazzaq G; Shanshal S; Alomari N
Ceska Slov Farm; 2023; 72(1):45-54. PubMed ID: 36858979
[TBL] [Abstract][Full Text] [Related]
43. Cutaneous adverse reactions to coronavirus vaccines: A Saudi nationwide study.
Bukhari AE; Almutlq MM; Bin Dakhil AA; Alhetheli GI; Alfouzan SK; Alqahtani MA; Aljalfan AA; Almutawa MA; Alsubaie FS; Madani AN
Dermatol Ther; 2022 Jun; 35(6):e15452. PubMed ID: 35293657
[TBL] [Abstract][Full Text] [Related]
44. Common Side Effects of Pfizer COVID-19 Vaccine: An Experience From Pakistan.
Haider SMS; Alvi SA; Khan H; Majeed R; Syed T; Anwar A; Hashmi AA
Cureus; 2023 Jun; 15(6):e40878. PubMed ID: 37492805
[TBL] [Abstract][Full Text] [Related]
45. COVID-19 Vaccine Knowledge and Attitude Among Healthcare Workers in Jeddah, Saudi Arabia.
Althaqafi A; Munshi A; Mujalled MK; Munshi E; Alhouthali A; Alqalayta L; Zahed H; Bahashwan MS; Alghubayshi L; Alghamdi A
Cureus; 2023 Jun; 15(6):e41070. PubMed ID: 37519596
[TBL] [Abstract][Full Text] [Related]
46. Acceptance and Attitude toward COVID-19 Vaccination among the Public in Saudi Arabia: A Cross-sectional Study.
Alduwayghiri EM; Khan N
J Contemp Dent Pract; 2021 Jul; 22(7):730-734. PubMed ID: 34615775
[TBL] [Abstract][Full Text] [Related]
47. The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.
Desalegn M; Garoma G; Tamrat H; Desta A; Prakash A
PLoS One; 2022; 17(6):e0265140. PubMed ID: 35749520
[TBL] [Abstract][Full Text] [Related]
48. Willingness to receive COVID-19 vaccination among adults with chronic diseases in the Kingdom of Saudi Arabia.
Al-Hanawi MK; Ahmad K; Haque R; Keramat SA
J Infect Public Health; 2021 Oct; 14(10):1489-1496. PubMed ID: 34417135
[TBL] [Abstract][Full Text] [Related]
49. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
Rosero-Bixby L
JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
[TBL] [Abstract][Full Text] [Related]
50. Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study.
Attash HM; Al-Obaidy LM; Al-Qazaz HK
Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214647
[TBL] [Abstract][Full Text] [Related]
51. Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects.
Hatmal MM; Al-Hatamleh MAI; Olaimat AN; Hatmal M; Alhaj-Qasem DM; Olaimat TM; Mohamud R
Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34073382
[TBL] [Abstract][Full Text] [Related]
52. Assessing the adverse effects of COVID-19 vaccine in different scenarios in Saudi Arabia: A cross-sectional study.
Alsaiari AA; Allahyani M; Aljuaid A; Shafie A; Al-Hazmi A; Dahlawi HA; Abdulaziz O; Alosimi E; Alzaidi A; Almehmadi M
Saudi Med J; 2023 Feb; 44(2):194-201. PubMed ID: 36773975
[TBL] [Abstract][Full Text] [Related]
53. Association between social media use and the acceptance of COVID-19 vaccination among the general population in Saudi Arabia - a cross-sectional study.
Othman SS; Alsuwaidi A; Aseel R; Alotaibi R; Bablgoom R; Alsulami G; Alharbi R; Ghamri R
BMC Public Health; 2022 Feb; 22(1):375. PubMed ID: 35189874
[TBL] [Abstract][Full Text] [Related]
54. Socio-Demographics Correlate of COVID-19 Vaccine Hesitancy During the Second Wave of COVID-19 Pandemic: A Cross-Sectional Web-Based Survey in Saudi Arabia.
Al-Mohaithef M; Padhi BK; Ennaceur S
Front Public Health; 2021; 9():698106. PubMed ID: 34249851
[No Abstract] [Full Text] [Related]
55. Evaluation of Short-Term Symptoms Associated With COVID-19 Vaccines Used Among Adolescents in Saudi Arabia.
Alrowdhan FK; Alwably A; Altala AS; Alfaraj H; Farawaty MN; Shaheen RS; Alenazi SA; Yousef EM
Cureus; 2022 Sep; 14(9):e29306. PubMed ID: 36277554
[TBL] [Abstract][Full Text] [Related]
56. COVID-19 Vaccine Impacts in Saudi Arabia: A Cross-Sectional Study.
Mohammedsaeed W; Alrashidi H; Alsharif SM; Aljardi O; Al-Sehli A
Cureus; 2023 Jun; 15(6):e40460. PubMed ID: 37456436
[TBL] [Abstract][Full Text] [Related]
57. Evaluating Pharmacists' Pharmacological Knowledge and Views Regarding Pfizer-BioNTech COVID-19 Vaccine in Saudi Arabia.
Alorfi N; Ashour A
Clin Pharmacol; 2022; 14():27-35. PubMed ID: 35411192
[TBL] [Abstract][Full Text] [Related]
58. The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study.
El-Shitany NA; Bagher AM; Binmahfouz LS; Eid BG; Almukadi H; Badr-Eldin SM; El-Hamamsy M; Mohammedsaleh ZM; Saleh FM; Almuhayawi MS; Alghamdi SA; Arab RA; Ali SS; Harakeh S; Alghamdi BS
Int J Gen Med; 2022; 15():6821-6836. PubMed ID: 36051568
[TBL] [Abstract][Full Text] [Related]
59. Reporting at Least One Adverse Effect Post-COVID-19 Vaccination From Primary Health Care in Muscat.
Al Ghafri TS; Al Balushi L; Al Balushi Z; Al Hinai F; Al Hasani S; Anwar H; Al Lawati M; Al Harthi S
Cureus; 2021 Aug; 13(8):e17055. PubMed ID: 34522533
[TBL] [Abstract][Full Text] [Related]
60. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
